Rondomized prospective trials of intravitreal bevacizumab alone versus combined with photocoagulation for ischmic lesion in retinal venous occlusion.

Rondomized prospective trials of intravitreal bevacizumab alone versus combined with photocoagulation for ischmic lesion in retinal venous occlusion. - Combination therapy of bevacizumab injection and photocoagulation for BRVO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009689

Enrollment

Registered

2013-01-10

Start date

2013-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema due to branch retinal vein occlusion

Interventions

Photocoagulation for non-perfusion areas after injection of bevacizumab. Injection of bevacizumab without photocoagulation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with branch retinal vein occlusion with macular edema were enrolled. Patient who obtained agreement after enough explanation when participating in this study is received.

Exclusion criteria

Exclusion criteria: History of ocular surgery, Ocular diseases except for branch retinal vein occlusion.

Design outcomes

Primary

Measure	Time frame
Central retinal thickness at 3 months after the injection of bevacizumab.	—

Secondary

Measure	Time frame
Best corrected visual acuity at 3 months after the injection of bevacizumab.	—

Countries

Japan

Contacts

Public ContactYoshihiro Takamura

Faculty of Medical Sciences, University of Fukui Department of Ophthalmology

ytakamura@hotmail.com0776618403

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026